IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000061 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
87,205
Total Value
$610,276.47
P&L
+inf% (+$2,795,231.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Business Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 17,037 | $0.00 | $0.00 | 47,338 | Direct | โ | View Details | |
EVP, Chief Business Officer | Common Stock | โ | Jan 16, 2026 | Sale | 6,907 | $75.75 | $523,205.25 | 40,431 | Direct | โ | View Details | |
EVP, Chief Business Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 2,850 | $0.00 | $0.00 | 5,921 | Indirect | by Spouse | View Details | |
EVP, Chief Business Officer | Common Stock | โ | Jan 16, 2026 | Sale | 1,149 | $75.78 | $87,071.22 | 4,772 | Indirect | by Spouse | View Details | |
EVP, Chief Business Officer | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 25,800 | $0.00 | $0.00 | 77,090 | Direct | โ | View Details | |
EVP, Chief Business Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 17,037 | $0.00 | $0.00 | 49,474 | Direct | โ | View Details | |
EVP, Chief Business Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 9,675 | $0.00 | $0.00 | 59,149 | Direct | โ | View Details | |
EVP, Chief Business Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 2,850 | $0.00 | $0.00 | 5,474 | Indirect | by Spouse | View Details | |
EVP, Chief Business Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 3,900 | $0.00 | $0.00 | 9,374 | Indirect | by Spouse | View Details |